Oxford Nanopore prevails against PacBio in decision by US Court of Appeal that upholds ITC ruling

Tue 12th February 2019 – Decision defeats attempts by PacBio to prevent Oxford Nanopore from selling its technology in the US – Oxford Nanopore announces that the US Court of Appeals for the Federal Circuit today upheld the decision of the International Trade Commission (ITC) in favour of Oxford Nanopore. In a complaint previously filed... Read more

RNA sequencing transformed: Oxford Nanopore introduces new cDNA Sequencing Kits

New generation direct cDNA and PCR-cDNA 109 Kits provide full-length cDNA transcripts at high yields. Oxford Nanopore has launched new ‘109’ cDNA Kits for its real-time, scalable sequencing technology. The new kits provide high throughput whilst generating complete sequences of full-length cDNA strands, with a low input option of just 1ng PolyA+ RNA. The new cDNA sequencing... Read more

Oxford Nanopore Prevails in Patent Ruling against Pacific Biosciences

January 22, 2019 09:04 AM Pacific Standard Time OXFORD, England–(BUSINESS WIRE)–Today the European Patent Office revoked Pacific Biosciences patent EP3045542 with claims to a single molecule sequencing process wherein two strands of DNA are linked by a connecting nucleic acid. The validity of the patent had been challenged by Oxford Nanopore. The EPO ruled that... Read more

Amgen invests £50 million ($66 million) in Oxford Nanopore Technologies

Thu 18th October 2018 THOUSAND OAKS, Calif. and OXFORD, England – (Oct. 18, 2018) – Amgen (NASDAQ:AMGN) and Oxford Nanopore Technologies Ltd. today announced Amgen’s equity investment of £50 million ($66 million) in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology. Oxford Nanopore has developed and brought to... Read more

Oxford Nanopore Launches MinIT, a Powerful Analysis Device to Enable Real Time, Portable DNA Sequencing

MinIT is out – an analysis and device control accessory to enable powerful, real-time DNA/RNA sequencing by anyone, anywhere Wed 10th October 2018 MinIT, a rapid analysis and device control accessory for nanopore DNA sequencing, is now arriving with genomics researchers. Scientists will use it to run the MinION DNA/RNA sequencer, opening up high-throughput, real-time... Read more

Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore

MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore and other parties of patent infringement litigation between the parties in the United Kingdom and Germany, under which Oxford Nanopore... Read more

Oxford Nanopore announces favourable outcome in UK and German patent litigation against Pacific Biosciences

Wed 9th May 2018 Oxford Nanopore and Pacific Biosciences have agreed to discontinue UK and German litigation. In the settlement, Oxford Nanopore agreed not to sell its 2D kits in UK and Germany. 2D is, in any case, obsolete and was globally discontinued in May 2017, when Oxford Nanopore replaced it with the superior 1D^2... Read more